Risk of hyperkalemia and combined use of spironolactone and long‐term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real‐life data: a population‐ and insurance‐based cohort
Year: 2015
Type: article
Study design: Observational Study
DOI: 10.1002/pds.3748
Institutions: University of Cologne, University Hospital Frankfurt
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: hyperkalemia, spironolactone, ACE inhibitors, angiotensin receptor blockers, heart failure, mineralocorticoid receptor antagonists, drug-drug interactions, potassium monitoring, NYHA functional class, elderly patients, real-world evidence, adverse drug reactions, health insurance claims data, Germany, AOK, antihypertensive therapy, renin-angiotensin system
Open Access status: closed
Funders: Merck KGaA, Medicines Company
OpenAlex ID: W2123461279
